Font Size: a A A

Prognosis And Prognostic Factors Of Local Advanced Low Rectal Carcinoma In The Anterior-lateral Wall

Posted on:2017-01-29Degree:MasterType:Thesis
Country:ChinaCandidate:W X XiaoFull Text:PDF
GTID:2334330503473661Subject:Surgery (general surgery)
Abstract/Summary:PDF Full Text Request
Objective: The primary aim of this study was to explore the prognostic factors of patients with locally advanced low rectal carcinoma in the anterior-lateral wall by comparing the prognosis with the patients of low rectal carcinoma in the posterior wall,and providing a reference for therapy choice for locally advanced low rectal carcinoma in the anterior-lateral wall.Methods: Retrospective analysis of 333 patients of low rectal cancer without distant metastases who were treated in the Department of Colorectal Surgery in Fujian Medical University Union Hospital from January 2008 to December 2012,which was assigned into two subgroups(anterior-lateral wall,posterior wall) according to the 7th General Rules for Clinical and Pathological Studies on Cancer of the Colon,Rectum and Anus.Preoperative T staging was evaluated according to The Radiologic Society of North America(RSNA) proposal criteria. The differences between two subgroups(anteriorlateral wall, posterior wall) on the prognosis and prognostic factors were retrospectively compared.Results: For the patients with locally advanced low rectal cancer, the anterior-lateral wall group and posterior wall group revealed no significant differences in the 3-year disease-free survival rate(76.9% vs 83.1%,P=0.227),local recurrence rate(13.3% vs7.7%,P=0.151)and distant metastatic rate(12.5% vs 15.8%,P=0.174).Univariate analysis showed that circumferential resection margin involvement, lymphatic metastasis, lower differentiation of tumor, non anus preserving operation(P<0.05 for all, OR> 1.0 for all)were significant prognostic factors for DFS. Cox multivariate analysis indicated that circumferential resection margin( CRM) involvement,lymphatic metastasis, non anus preserving operation(P<0.05 for all) was independent prognostic factor for DFS. The patients between the two subgroups(anterior-lateral wall,posterior wall) who received neoadjuvant radiochemotherapy revealed no significant differences in metastasis rate of lymph nodes(30.3% vs 37.5%,P=0.340),the patients treated by surgery only between the two groups revealed no significant differences in metastasis rate of lymph nodes either.The rate of CRM involvement(6.9% vs 3.9%,P=0.683)had no significant differences between the clinical T3 stage anterior-lateral wall group and the clinical T3 stage posterior wall group after neoadjuvant radiochemotherapy.The same T stage patients treated by surgery only were significantly different in the rate of CRM involvement(14.3% vs 0.0%,P=0.022)between the two groups.Conclusions:For the patients with locally advanced low rectal carcinoma in the anterior-lateral wall, the rate of CRM involvement were significantly different from the patients with local advanced low rectal carcinoma in the posterior wall,while the rate reduced when T3 stage patients with low rectal cancer in the anter-ior-lateral wall received neoadjuvant radiochemotherapy. CRM involvement, lymphatic metastasis,non anus preserving operation were independent prognostic factors for patients with low rectal cancer in the anterior-lateral wall.
Keywords/Search Tags:Low rectal cancer in the anterior-lateral wall, T staging, CRM involvement, lymphatic metastasis, neoadjuvant radiochemotherapy
PDF Full Text Request
Related items
Study On The Efficacy Of Neoadjuvant Radiochemotherapy In The Treatment Of T3 Mid-low Rectal Cancer
Detecting The Hight Risk Of Regional Lymph Node Metastasis After Neoadjuvant Chemoradiotherapy For Local Advanced Rectal Cancer And A Scoring System To Predict Its Involvement In Rectal Cancer
Prediction Of Radiochemosensitivity By Next Generation Sequencing In Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Radiochemotherapy
Preliminary Study On Genes Related To Predicting The Efficacy Of Neoadjuvant Radiochemotherapy In Locally Advanced Rectal Cancer
Predictive Factors And Surgical Safety Analysis For Pathological Lateral Pelvic Node Metastasis In Rectal Cancer Patients With Clinical Lateral Pelvic Node Metastasis After Neoadjuvant Chemoradiotherapy
Clinical Analysis Of XPC,ERCC1 And XRCC1 Gene Polymorphisms And Sensitivity Of Neoadjuvant Radiochemotherapy For Rectal Cancer
PART Ⅰ:staging Optimization For Rectal Cancer After Neoadjuvant Therapy PART Ⅱ:prediction For Lymph Node Metastasis In Rectal Cancer Based On Transcriptomics
Neoadjuvant Radiochemotherapy And Chemotherapy For The Treatment Of Advanced Low Rectal Cancer And Analysis Of The Expression Of MMP-2 In Cancer Tissue
1.The Prognostic Significance Of The Treatment Response Of Regional Lymph Nodes And The Refinement Of Current TNM Staging System In Locally Advanced Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy 2.The Safety And Efficacy Of Radical Surgery Fo
10 A Comparative Study On Diagnostic Value Of MSCT And Mri In Preoperative Local Staging For Rectal Cancer After Neoadjuvant Chemoradiotherapy